Autologous Mononuclear Cell Collection Services
Autologous Mononuclear Cell Collection Services
Experience You Can Trust with a Nationwide Reach
Experience You Can Trust with a Nationwide Reach
Join American Red Cross Cell and Gene Therapy Solutions on January 20-23, 2025, in Dallas, TX at Advanced Therapies Week. Stop by and visit us at booth 452 in the Exhibit Hall at the Kay Bailey Hutchison Convention Center.
With sites across the nation, the American Red Cross is the largest single provider of autologous Mononuclear Cell (MNC) Collections for cell therapy and a proven partner in providing patient access to our client’s drug or developing cell therapy products requiring a MNC collection.
Economies of scale and cross-utilization of technology allow us to offer you cost-effective autologous collection services and provide high-quality source material for commercial production as well for clinical trials.
A Nationwide Network of Collection Sites
Your nationwide partner for all your autologous MNC collection needs
Since 2010 the American Red Cross has played an essential role in the delivery of PROVENGE® (sipuleucel-T) – an autologous cellular immunotherapy for the treatment of men with advanced prostate cancer. Their national network of blood collection centers facilitate the successful commercial delivery of PROVENGE and ensure convenient access to services for PROVENGE patients nationwide. We are grateful to the American Red Cross for their support and strong partnership. Equally innovative and reliable, we value their expertise, attention to detail and shared commitment to our patients.
- Serena Stewart Vice President, Patient Operations Dendreon Pharmaceuticals
American Red Cross Cell and Gene Therapy Solutions Fireside Chat with Dendreon
Advanced Therapies Connect 2021, Jan 26-27, 2021
Learn how the we were able to keep patients safe, keep our collection centers open and help Dendreon continue to provide life-saving therapy during the COVID-19 pandemic.
You can also reach an account executive by calling 833-760-0625.
We look forward to speaking with you.